All In Biotech

Drug Trial Radar · NCT01233167

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation

Benefits and Risks Evaluation of Different Anti-platelet Strategies Beyond a 12-month Period Inpatients Receiving Sirolimus Drug-eluting Stent Implantation

Last checked: Nov 19, 2026Latest source record: Jul 20, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 5,232 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

5,232

Planned (sponsor's estimate)

Start

Aug 2011

Primary completion

Dec 2012

Study completion May 2013

Sponsor

Lead sponsor
Sir Run Run Shaw HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 3, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aims to assess the effectiveness of dual antiplatelet therapy, aspirin alone versus steeply discontinued clopidogrel plus aspirin in preventing clinical MACE events.Our subject is beyond a 12-month period patients receiving sirolimus drug-eluting stent implantation.

Conditions

  • Coronary Artery Disease

Interventions

  • clopidogrelDrug

    clopidogrel 75 mg po per day for 12 months

  • placeboDrug

    placebo 75mg po per day for 12 months

  • clopidogrel and placeboDrug

    clopidogrel 50mg per day for 3 months,clopidogrel 25mg per day for 3 months,then placebo 75mg per day for 6 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. all cause mortalityTime frame: one year
  2. nonfatal myocardial infarctionTime frame: one year
  3. clinical-driven target vessel revascularizationTime frame: one year
  4. cardiac deathTime frame: one year
  5. stent thrombosisTime frame: one year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.